This page shows Glaukos Corp (GKOS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Glaukos Corp generated $383.5M in revenue in fiscal year 2024. This represents an increase of 21.9% from the prior year.
Glaukos Corp's EBITDA was -$86.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 8.8% from the prior year.
Glaukos Corp generated -$67.6M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 13.3% from the prior year.
Glaukos Corp reported -$146.4M in net income in fiscal year 2024. This represents a decrease of 8.7% from the prior year.
Glaukos Corp earned $-2.77 per diluted share (EPS) in fiscal year 2024. This represents an increase of 0.4% from the prior year.
Glaukos Corp held $169.6M in cash against $0 in long-term debt as of fiscal year 2024.
Glaukos Corp had 56M shares outstanding in fiscal year 2024. This represents an increase of 14.9% from the prior year.
Glaukos Corp's gross margin was 75.5% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 0.5 percentage points from the prior year.
Glaukos Corp's operating margin was -31.9% in fiscal year 2024, reflecting core business profitability. This is up 9.0 percentage points from the prior year.
Glaukos Corp's net profit margin was -38.2% in fiscal year 2024, showing the share of revenue converted to profit. This is up 4.6 percentage points from the prior year.
Glaukos Corp invested $136.4M in research and development in fiscal year 2024. This represents a decrease of 1.7% from the prior year.
Glaukos Corp invested $6.3M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 68.9% from the prior year.
GKOS Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $133.5M+7.6% | $124.1M+16.4% | $106.7M+1.1% | $105.5M+9.1% | $96.7M+1.0% | $95.7M+11.8% | $85.6M+4.0% | $82.4M |
| Cost of Revenue | $28.8M+7.2% | $26.9M+10.6% | $24.3M-15.1% | $28.6M+26.8% | $22.6M+0.2% | $22.6M+11.3% | $20.3M+7.2% | $18.9M |
| Gross Profit | $104.7M+7.7% | $97.2M+18.1% | $82.3M+7.1% | $76.9M+3.7% | $74.1M+1.3% | $73.1M+11.9% | $65.4M+3.0% | $63.5M |
| R&D Expenses | $38.1M+4.2% | $36.5M+12.9% | $32.4M-11.4% | $36.5M+5.1% | $34.7M+0.9% | $34.4M+12.0% | $30.7M-17.1% | $37.1M |
| SG&A Expenses | $83.0M-0.5% | $83.4M+18.0% | $70.7M+2.4% | $69.0M+7.8% | $64.0M-3.3% | $66.2M+6.8% | $62.0M-1.7% | $63.0M |
| Operating Income | -$16.4M+27.9% | -$22.7M-9.7% | -$20.7M+27.9% | -$28.7M-16.2% | -$24.7M+17.7% | -$30.0M+23.3% | -$39.1M-1.1% | -$38.6M |
| Interest Expense | $1.2M+2.1% | $1.2M-1.0% | $1.2M-26.0% | $1.6M-5.5% | $1.7M-50.4% | $3.4M-2.8% | $3.5M+0.6% | $3.4M |
| Income Tax | $234K-5.6% | $248K-23.9% | $326K+386.0% | -$114K-164.4% | $177K-46.5% | $331K-12.2% | $377K+518.0% | $61K |
| Net Income | -$16.2M+17.4% | -$19.7M-8.3% | -$18.1M+46.0% | -$33.6M-56.8% | -$21.4M+57.6% | -$50.5M-23.8% | -$40.8M-11.0% | -$36.8M |
| EPS (Diluted) | $-0.28+17.6% | $-0.34-6.3% | $-0.32+42.9% | $-0.56-43.6% | $-0.39+61.0% | $-1.00-22.0% | $-0.82-9.3% | $-0.75 |
GKOS Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $999.4M+1.3% | $987.0M+2.2% | $966.2M-0.9% | $974.8M+5.2% | $926.5M+0.7% | $919.7M-1.5% | $933.3M-0.8% | $940.4M |
| Current Assets | $454.8M+4.3% | $436.1M-1.9% | $444.5M-1.2% | $449.8M+13.2% | $397.3M+3.5% | $383.8M-1.2% | $388.6M-1.7% | $395.5M |
| Cash & Equivalents | $98.2M-2.5% | $100.8M-11.8% | $114.3M-32.6% | $169.6M+69.4% | $100.1M+47.1% | $68.1M+60.2% | $42.5M-54.5% | $93.5M |
| Inventory | $63.9M-1.2% | $64.6M+8.7% | $59.5M+3.1% | $57.7M-3.7% | $59.9M+6.0% | $56.5M+12.5% | $50.2M+19.5% | $42.0M |
| Accounts Receivable | $98.7M+18.9% | $83.0M+16.0% | $71.5M+17.8% | $60.7M+7.7% | $56.4M+10.1% | $51.2M+10.0% | $46.5M+16.8% | $39.9M |
| Goodwill | $66.7M0.0% | $66.7M+0.9% | $66.1M0.0% | $66.1M0.0% | $66.1M0.0% | $66.1M0.0% | $66.1M0.0% | $66.1M |
| Total Liabilities | $229.8M+3.6% | $221.8M+9.7% | $202.2M-2.7% | $207.8M-19.5% | $258.0M+1.4% | $254.5M-47.3% | $482.6M+0.8% | $478.6M |
| Current Liabilities | $87.5M+10.6% | $79.1M+15.5% | $68.5M-8.8% | $75.1M+4.8% | $71.7M+2.3% | $70.1M-3.0% | $72.2M-2.4% | $74.0M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $769.5M+0.6% | $765.1M+0.2% | $764.0M-0.4% | $766.9M+14.7% | $668.5M+0.5% | $665.2M+47.6% | $450.7M-2.4% | $461.8M |
| Retained Earnings | -$799.5M-2.1% | -$783.2M-2.6% | -$763.6M-2.4% | -$745.4M-4.7% | -$711.9M-3.1% | -$690.5M-7.9% | -$639.9M-6.8% | -$599.1M |
GKOS Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | -$18.5M | N/A | N/A | N/A | -$33.9M | N/A |
| Capital Expenditures | N/A | N/A | $1.9M | N/A | N/A | N/A | $968K | N/A |
| Free Cash Flow | N/A | N/A | -$20.5M | N/A | N/A | N/A | -$34.8M | N/A |
| Investing Cash Flow | N/A | N/A | -$36.9M | N/A | N/A | N/A | -$29.4M | N/A |
| Financing Cash Flow | N/A | N/A | $1.9M | N/A | N/A | N/A | $13.2M | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GKOS Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.4%+0.1pp | 78.3%+1.1pp | 77.2%+4.3pp | 72.9%-3.8pp | 76.6%+0.2pp | 76.4%+0.1pp | 76.3%-0.7pp | 77.1% |
| Operating Margin | -12.3%+6.0pp | -18.3%+1.1pp | -19.4%+7.8pp | -27.2%-1.7pp | -25.5%+5.8pp | -31.3%+14.3pp | -45.6%+1.3pp | -46.9% |
| Net Margin | -12.2%+3.7pp | -15.8%+1.2pp | -17.0%+14.8pp | -31.8%-9.7pp | -22.1%+30.7pp | -52.8%-5.1pp | -47.7%-3.0pp | -44.6% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -1.6%+0.4pp | -2.0%-0.1pp | -1.9%+1.6pp | -3.4%-1.1pp | -2.3%+3.2pp | -5.5%-1.1pp | -4.4%-0.5pp | -3.9% |
| Current Ratio | 5.20-0.3 | 5.51-1.0 | 6.49+0.5 | 5.99+0.4 | 5.54+0.1 | 5.48+0.1 | 5.38+0.0 | 5.34 |
| Debt-to-Equity | 0.300.0 | 0.29+0.0 | 0.260.0 | 0.27-0.1 | 0.390.0 | 0.38-0.7 | 1.07+0.0 | 1.04 |
| FCF Margin | N/A | N/A | -19.2% | N/A | N/A | N/A | -40.7% | N/A |
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks.
Financial strength trend (9 signals). 7-9 = strong, 0-3 = weak.
Operating cash flow vs net income. Above 1.0x = cash-backed earnings.
Operating income vs interest expense. Above 5x = safe, below 2x = risky.
Similar Companies
Frequently Asked Questions
What is Glaukos Corp's annual revenue?
Glaukos Corp (GKOS) reported $383.5M in total revenue for fiscal year 2024. This represents a 21.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Glaukos Corp's revenue growing?
Glaukos Corp (GKOS) revenue grew by 21.9% year-over-year, from $314.7M to $383.5M in fiscal year 2024.
Is Glaukos Corp profitable?
No, Glaukos Corp (GKOS) reported a net income of -$146.4M in fiscal year 2024, with a net profit margin of -38.2%.
What is Glaukos Corp's earnings per share (EPS)?
Glaukos Corp (GKOS) reported diluted earnings per share of $-2.77 for fiscal year 2024. This represents a 0.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Glaukos Corp's EBITDA?
Glaukos Corp (GKOS) had EBITDA of -$86.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Glaukos Corp's gross margin?
Glaukos Corp (GKOS) had a gross margin of 75.5% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Glaukos Corp's operating margin?
Glaukos Corp (GKOS) had an operating margin of -31.9% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Glaukos Corp's net profit margin?
Glaukos Corp (GKOS) had a net profit margin of -38.2% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Glaukos Corp's free cash flow?
Glaukos Corp (GKOS) generated -$67.6M in free cash flow during fiscal year 2024. This represents a 13.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Glaukos Corp's operating cash flow?
Glaukos Corp (GKOS) generated -$61.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Glaukos Corp's total assets?
Glaukos Corp (GKOS) had $974.8M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Glaukos Corp's capital expenditures?
Glaukos Corp (GKOS) invested $6.3M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Glaukos Corp spend on research and development?
Glaukos Corp (GKOS) invested $136.4M in research and development during fiscal year 2024.
How many shares does Glaukos Corp have outstanding?
Glaukos Corp (GKOS) had 56M shares outstanding as of fiscal year 2024.
What is Glaukos Corp's current ratio?
Glaukos Corp (GKOS) had a current ratio of 5.99 as of fiscal year 2024, which is generally considered healthy.
What is Glaukos Corp's debt-to-equity ratio?
Glaukos Corp (GKOS) had a debt-to-equity ratio of 0.27 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Glaukos Corp's return on assets (ROA)?
Glaukos Corp (GKOS) had a return on assets of -15.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Glaukos Corp's cash runway?
Based on fiscal year 2024 data, Glaukos Corp (GKOS) had $169.6M in cash against an annual operating cash burn of $61.3M. This gives an estimated cash runway of approximately 33 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Glaukos Corp's Piotroski F-Score?
Glaukos Corp (GKOS) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals.
Are Glaukos Corp's earnings high quality?
Glaukos Corp (GKOS) has an earnings quality ratio of 0.42x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation.
Can Glaukos Corp cover its interest payments?
Glaukos Corp (GKOS) has an interest coverage ratio of -12.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline.
How financially healthy is Glaukos Corp?
Glaukos Corp (GKOS) scores 58 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks.